Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Edgewise Therapeutics, Inc. (EWTX) had Pre-Tax Income of $-57.33M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-57.33M |
|
-- |
|
-- |
|
$61.94M |
|
$-61.94M |
|
$4.62M |
|
|
Pre-Tax Income |
$-57.33M |
$-57.33M |
|
$-57.33M |
|
$-57.33M |
|
$-57.33M |
|
$-57.33M |
|
$-61.94M |
|
$-62.16M |
|
107.67M |
|
107.67M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$471.52M |
|
$6.89M |
|
$8.17M |
|
$479.69M |
|
$29.04M |
|
-- |
|
$2.57M |
|
$31.61M |
|
$448.08M |
|
$448.08M |
|
$448.08M |
|
107.78M |
|
| Cash Flow Statement Financials | |
$-85.01M |
|
$80.92M |
|
$15.26M |
|
$61.15M |
|
$72.32M |
|
$11.17M |
|
$18.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-85.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.79% |
|
-12.79% |
|
-11.95% |
|
-12.79% |
|
$4.16 |
|
$-0.79 |
|
$-0.79 |
|